Iridex reported a net loss of $3.6 million in the first quarter of 2018 compared with a net loss of $1.9 million in 2017’s first quarter.
Operating expenses for the quarter rose from $6.3 million in 2017 to $7.5 million this year, which Iridex attributed to investments supporting its commercial infrastructure, including sales and marketing expense increases, according to a press release.
Revenue was down from $10.5 million in the first quarter of 2017 to $9.5 million. The decrease was attributed to lower retina product revenues due to the voluntary (Read more...)
Uncategorized